We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Environmental diabetogens: biochemical links between microplastic exposure, endocrine disruption, and glucose metabolic dysfunction
AI summary Read the abstract
This review pulls together existing research suggesting that microplastics—and the chemicals they carry, like BPA and phthalates—may disrupt your body's hormones and cell signaling in ways that interfere with how you process blood sugar, potentially contributing to insulin resistance and type 2 diabetes. While this doesn't prove microplastics *cause* diabetes in humans, it highlights a plausible biological pathway that adds to concerns about our everyday exposure to plastics in food, water, and packaging. More research is needed, but this is a reminder that reducing plastic exposure could be one more piece of the puzzle in protec
The increase in the incidence of type 2 diabetes mellitus (T2DM) worldwide cannot be attributed solely to genetic and lifestyle factors, underscoring the growing role of environmental metabolic disruptors. Microplastics are increasingly being identified as potential environmental diabetogens, owing to the high risk of human exposure and the potential of microplastics to act as EDC carriers. This review aims to integrate the biochemical and molecular evidence for the association between microplastic exposure and the development of impaired glucose metabolism via endocrine, inflammatory, and metabolic signaling pathways. These microplastics and additives, such as bisphenols, phthalates, and POPs, interact with nuclear hormone receptors, including the estrogen receptor, peroxisome proliferator-activated receptor, and aryl hydrocarbon receptor, resulting in aberrant transcriptional control of genes involved in the regulation of metabolism. Microplastics exposure may cause oxidative stress-mediated activation of stress kinases, inhibition of insulin receptor substrate-1, suppression of PI3K-Akt signaling, GLUT4 translocation, and mitochondrial dysfunction, which together result in systemic insulin resistance. In addition, β-cell damage, systemic inflammation, and changes in the gut microbiome interfere with the regulation of glucose metabolism in the liver, muscle, and adipose tissues.
More Papers Like This
Microplastics and Nanoplastics as Potential Metabolic Disruptors: Implications for Insulin Resistance and Type 2 Diabetes
AI summary Read the abstract
Tiny plastic particles have been found throughout our bodies—in blood, lung tissue, even the placenta—and this review explores early evidence that they might disrupt gut health and metabolism in ways that could contribute to insulin resistance and type 2 diabetes. The theory: these particles may damage the gut lining, throw off gut bacteria and digestive hormones, and trigger low-level inflammation in the liver. It's important to note this is still a hypothesis based mostly on animal studies, not proof that microplastics cause diabetes in humans, but it highlights a research area worth watching closely.
Exploring the micro- and nanoplastics–diabetes nexus: Shattered barriers, toxic links, and methodological horizons
AI summary Read the abstract
This review examines growing evidence that micro- and nanoplastics may contribute to diabetes by disrupting blood sugar regulation, insulin signaling, and fat metabolism through oxidative stress and inflammation. Animal studies show that plastic particles can damage the pancreas, liver, and gut in ways that mirror the development of diabetes, though human studies are still limited. The review calls for more research into whether everyday microplastic exposure could be a hidden factor in the global rise of metabolic diseases.
Environmental Insults to Glucose Metabolism: The Role of Pollutants in Insulin Resistance
AI summary Read the abstract
This review examines how environmental pollutants, including microplastics, contribute to insulin resistance, a condition where the body's cells respond poorly to insulin. Researchers summarize evidence linking pollutant exposure to disruptions in glucose and lipid metabolism through mechanisms like oxidative stress and inflammation. The study suggests that environmental contamination may be an underrecognized factor in the growing prevalence of metabolic conditions such as type 2 diabetes.
New Insights into the Relationship Between Microplastics and Diabetes from the Perspective of the Gut–Liver Axis and Macrophage Regulation
AI summary Read the abstract
This review paper summarizes research suggesting that tiny plastic particles (microplastics) we're exposed to from the environment might increase the risk of developing type 2 diabetes. The studies show microplastics could damage the gut, trigger inflammation, and disrupt how the body processes sugar, though this evidence comes mainly from animal studies rather than human research. While more human studies are needed to confirm these effects, the findings suggest reducing plastic pollution could be important for preventing diabetes and other metabolic diseases.
Plasticizing Diabetes Care: The Metabolic Threat of Plastic-Associated Endocrine Disruptors and Micro-/Nanoplastics in Clinical Medicine
AI summary Read the abstract
This review paper looks at how the plastic used in diabetes supplies—like insulin pumps, tubing, and glucose monitors—may expose patients to chemicals and tiny plastic particles that can disrupt hormones and worsen metabolic health. While scientists don't yet know exactly how much these plastics contribute to diabetes risk, the research suggests it's a bigger concern than most people realize, and reducing plastic exposure in medical care could benefit both patients and the environment.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.